Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Conditions
Schizophrenia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Neurocrine Clinical Site, Garden Grove, California, United States
Neurocrine Clinical Site, La Habra, California, United States
Neurocrine Clinical Site, Lemon Grove, California, United States
Neurocrine Clinical Site, Oceanside, California, United States
Neurocrine Clinical Site, Torrance, California, United States
Neurocrine Clinical Site, West Hills, California, United States
Neurocrine Clinical Site, Hollywood, Florida, United States
Neurocrine Clinical Site, Maitland, Florida, United States
Neurocrine Clinical Site, Miami, Florida, United States
Neurocrine Clinical Site, Miami, Florida, United States
Neurocrine Clinical Site, Tampa, Florida, United States
Neurocrine Clinical Site, West Palm Beach, Florida, United States
Neurocrine Clinical Site, Atlanta, Georgia, United States
Neurocrine Clinical Site, Boston, Massachusetts, United States
Neurocrine Clinical Site, Flowood, Mississippi, United States
Neurocrine Clinical Site, Cedarhurst, New York, United States
Neurocrine Clinical Site, New York, New York, United States
Neurocrine Clinical Site, New York, New York, United States
Neurocrine Clinical Site, The Bronx, New York, United States
Neurocrine Clinical Site, Bellevue, Washington, United States
Study leads
Clinical Development Lead
Study Director
Neurocrine Biosciences